Significant and Meaningful Improvement in Treatment Satisfaction with Teriflunomide Versus Subcutaneous IFNB-1A in Patients with Relapsing MS Results from Tenere
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.927
https://www.valueinhealthjournal.com/article/S1098-3015(14)02857-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
439
First Page :
A403
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02857-5&doi=10.1016/j.jval.2014.08.927